In this issue:
Anti-MAdCAM antibody effective and safe for UC
Efficacy of probiotics in IBD
Vedolizumab for 1 year in IBD
Reducing IBD azathioprine dose when combined with infliximab
MEDI2070, an IL-23 inhibitor, in moderate-to-severe CD
Infliximab-induced TB in UC in India
Budesonide-MMX for mesalazinerefractory, mild-to-moderate UC
Appendicectomy does not decrease future colectomy risk in UC
Induction and maintenance tofacitinib in CD
FUSE improves surveillance for dysplasia in IBD
Please login below to download this issue (PDF)